Azitra, Inc. Shareholders' Equity
Azitra, Inc. (AZTR) had Shareholders' Equity of $7.33 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $7.33M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.48M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $3.80M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.28M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $7.33M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.48M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $3.80M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $2.28M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.23M 10-Q · filed 2026-08-12 | $2.23M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.41M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $5.70M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $8.06M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.73M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $4.32M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $2.91M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $5.33M 10-Q · filed 2024-11-12 | $5.33M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $7.24M 10-Q · filed 2024-11-12 | $7.24M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$38.68M 10-Q · filed 2024-11-12 | -$38.68M 10-Q · filed 2023-08-14 |
| 2022-12-31 | -$36.26M 10-K · filed 2025-02-24 | |
| 2022-09-30 | -$32.24M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$29.87M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$28.03M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | -$25.77M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |